10 clinical trials to watch in the first half of 2025 Expected readouts in diabetes, most cancers and melancholy headline a series of research outcomes that could help the biotechnology sector get back its footing after a shaky year.That’s an enormous variation! As with any medication, results differ particular person by human being, but as a who